Extremely meaningful negative changes in fundamentals have recently occurred for World Fuel Services Corp (NYSE: INT): significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and […]
For its third fiscal quarter (ending September 30), Medifast Inc. (NYSE: MED) has reported a -36% decline in E.P.S. from $3.30 a year ago to $2.12 in the current quarter. However, this result exceeded the […]
Amkor Technology Inc (NASDAQ: AMKR). Extremely significant negative changes in fundamentals have recently occurred: the stock’s power rating fell below 50, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2024 decreased significantly, significant […]
Ameresco Inc (NYSE: AMRC) has reported earnings for its third fiscal quarter (ending September 30) of $0.41 versus $0.53 for the same period a year ago — a decline of -23%. This result fell short […]
Fabrinet (NYSE: FN) has reported E.P.S. of $1.80 for its first fiscal quarter (ending September 30) versus $1.77 for the same period a year ago — an increase of 2%. Relative to the consensus estimate […]
For its third fiscal quarter (ending September 30), Coterra Energy Inc (NYSE: CTRA) has reported a -72% decline in E.P.S. from $1.51 a year ago to $0.43 in the current quarter. This performance was $-0.00 […]
Celldex Therapeutics Inc (NASDAQ: CLDX) stock closed at $29.35 on 11/6/23 after a major increase of 13.0%. Relative to the market the stock has been weak over the last nine months but has risen 29.8% […]
For its third fiscal quarter (ending September 30), EchoStar Corp (NASDAQ: SATS) has reported a -85% decline in E.P.S. from $0.27 a year ago to $0.04 in the current quarter. For the latest four quarters […]
TreeHouse Foods Inc (NYSE: THS) has reported earnings for its third fiscal quarter (ending September 30) of $0.18 versus a loss $-0.27 for the same period a year ago. This performance was $-0.34 short of […]
OptimizeRX Corp (NASDAQ: OPRX) has reported E.P.S. of $-0.17 for its third fiscal quarter (ending September 30) versus $-0.19 for the same period a year ago. This performance was $-0.21 short of the consensus estimate […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research